Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prognostic factors for regression from impaired glucose tolerance to normal glucose regulation in Japanese patients with nonalcoholic fatty liver disease.
Ogata C, Ohmoto-Sekine Y, Tanabe M, Iwao A, Hsieh SD, Amakawa K, Matsumoto N, Ogawa K, Arimoto S, Okuda C, Shiba M, Kato H, Hashimoto M, Ishihara M, Tsuji H, Hara S, Arase Y. Ogata C, et al. Among authors: amakawa k. Intern Med. 2014;53(13):1401-6. doi: 10.2169/internalmedicine.53.1585. Epub 2014 Jun 15. Intern Med. 2014. PMID: 24990331 Free article.
The development of chronic kidney disease in Japanese patients with non-alcoholic fatty liver disease.
Arase Y, Suzuki F, Kobayashi M, Suzuki Y, Kawamura Y, Matsumoto N, Akuta N, Kobayashi M, Sezaki H, Saito S, Hosaka T, Ikeda K, Kumada H, Ohmoto Y, Amakawa K, Tsuji H, Hsieh SD, Kato K, Tanabe M, Ogawa K, Hara S, Kobayashi T. Arase Y, et al. Among authors: amakawa k. Intern Med. 2011;50(10):1081-7. doi: 10.2169/internalmedicine.50.5043. Epub 2011 May 1. Intern Med. 2011. PMID: 21576832 Free article.
Significance of oral glucose tolerance tests in non-alcoholic fatty liver disease patients with a fasting plasma glucose level of <126 mg/dL and HbA1c level of ≤ 6.4% in Japan.
Matsumoto N, Arase Y, Kawamura Y, Ohmoto-Sekine M, Amakawa K, Ogawa K, Tsuji H, Dong HS, Hara S, Akuta N, Suzuki F, Suzuki Y, Ikeda K, Kumada H, Kobayashi T. Matsumoto N, et al. Among authors: amakawa k. Intern Med. 2015;54(8):875-80. doi: 10.2169/internalmedicine.54.3437. Epub 2015 Apr 15. Intern Med. 2015. PMID: 25876566 Free article.
Relationship between Alcohol Intake and Risk Factors for Metabolic Syndrome in Men.
Hirakawa M, Arase Y, Amakawa K, Ohmoto-Sekine Y, Ishihara M, Shiba M, Ogawa K, Okuda C, Jinno T, Kato H, Tsuji H, Hashimoto M, Yamamoto T, Arimoto S, Hara S. Hirakawa M, et al. Among authors: amakawa k. Intern Med. 2015;54(17):2139-45. doi: 10.2169/internalmedicine.54.2736. Epub 2015 Sep 1. Intern Med. 2015. PMID: 26328637 Free article.
Virus clearance reduces bone fracture in postmenopausal women with osteoporosis and chronic liver disease caused by hepatitis C virus.
Arase Y, Suzuki F, Suzuki Y, Akuta N, Kobayashi M, Sezaki H, Hosaka T, Kawamura Y, Yatsuji H, Hirakawa M, Ikeda K, Hsieh SD, Oomoto Y, Amakawa K, Kato H, Kazawa T, Tsuji H, Kobayashi T, Kumada H. Arase Y, et al. Among authors: amakawa k. J Med Virol. 2010 Mar;82(3):390-5. doi: 10.1002/jmv.21691. J Med Virol. 2010. PMID: 20087925
Large-scale long-term follow-up study of Japanese patients with non-alcoholic Fatty liver disease for the onset of hepatocellular carcinoma.
Kawamura Y, Arase Y, Ikeda K, Seko Y, Imai N, Hosaka T, Kobayashi M, Saitoh S, Sezaki H, Akuta N, Suzuki F, Suzuki Y, Ohmoto Y, Amakawa K, Tsuji H, Kumada H. Kawamura Y, et al. Among authors: amakawa k. Am J Gastroenterol. 2012 Feb;107(2):253-61. doi: 10.1038/ajg.2011.327. Epub 2011 Oct 18. Am J Gastroenterol. 2012. PMID: 22008893
Difference in malignancies of chronic liver disease due to non-alcoholic fatty liver disease or hepatitis C in Japanese elderly patients.
Arase Y, Kobayashi M, Suzuki F, Suzuki Y, Kawamura Y, Akuta N, Imai N, Kobayashi M, Sezaki H, Matsumoto N, Saito S, Hosaka T, Ikeda K, Kumada H, Ohmoto Y, Amakawa K, Hsieh SD, Ogawa K, Tanabe M, Tsuji H, Kobayashi T. Arase Y, et al. Among authors: amakawa k. Hepatol Res. 2012 Mar;42(3):264-72. doi: 10.1111/j.1872-034X.2011.00915.x. Epub 2011 Dec 19. Hepatol Res. 2012. PMID: 22175908
Efficacy and safety in sitagliptin therapy for diabetes complicated by non-alcoholic fatty liver disease.
Arase Y, Kawamura Y, Seko Y, Kobayashi M, Suzuki F, Suzuki Y, Akuta N, Kobayashi M, Sezaki H, Saito S, Hosaka T, Ikeda K, Kumada H, Ohmoto-Sekine Y, Hsieh SD, Amakawa K, Ogawa K, Matsumoto N, Iwao A, Tsuji H, Hara S, Mori Y, Okubo M, Sone H, Kobayashi T. Arase Y, et al. Among authors: amakawa k. Hepatol Res. 2013 Nov;43(11):1163-8. doi: 10.1111/hepr.12077. Epub 2013 Mar 12. Hepatol Res. 2013. PMID: 23489256
44 results